Iptacopan targets one of the major proteins involved in the enzymes of the alternative pathway of complement, explains Carla ...

Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Friday, June 27, 2025, starting at 10 ...

Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis.

"We look forward to discussing the data with regulators so we can bring this first-in-class alternative complement pathway inhibitor as the first oral monotherapy to people living with PNH," he added.

Resistance to synthetic antibiotics poses a critical global health challenge. Various European honeybee and other natural ...

For more than a decade, commentators, analysts and industry have warned Australian governments about fuel vulnerability. Yet ...

These critical issues were discussed during the Banking Reinvented event by ENGAGE Dubai organised by Backbase ...

Exam fraud in Nigeria has become a deep-rooted crisis, threatening the foundation of education, integrity, and national ...

Waldenstrom Macroglobulinemia sees growing innovation as next-gen BTK inhibitors and novel therapies aim to overcome resistance and reshape treatment pathways. BTK inhibitors laid the groundwork, but ...

SEATTLE, WA, USA I June 27, 2025 I Omeros Corporation (Nasdaq: OMER) today announced the recent submission of a Marketing Authorization Application (MAA) to ...

The thing with trilogies though, is that the third instalment is often the worst, so let’s see whether Fuga: Melodies of Steel 3 can buck the trend and deliver a befitting finale. If you haven’t ...